Now Reading: Quadrise Extends Nouryon Partnership to Advance MSAR and bioMSAR Commercialisation
-
01
Quadrise Extends Nouryon Partnership to Advance MSAR and bioMSAR Commercialisation
Quadrise Extends Nouryon Partnership to Advance MSAR and bioMSAR Commercialisation
Quadrise has extended its Nouryon collaboration, supporting continued development and commercialisation of MSAR and bioMSAR fuel technologies.
Quadrise has extended its collaboration with specialty chemicals group Nouryon as the AIM-listed fuel technology company continues work to commercialise its MSAR and bioMSAR emulsion-fuel technologies.
Quadrise PLC has extended its agreement with Nouryon, maintaining access to specialist chemicals and technical support used in the development and deployment of MSAR and bioMSAR. The extension supports Quadrise’s ongoing commercial programmes in lower-cost and lower-emission alternatives to conventional heavy fuel oil.
The agreement preserves an important supply and technical relationship as Quadrise seeks to move projects from trials toward commercial revenues. For investors, progress with established industrial partners can reduce execution risk, although commercial-scale adoption and binding customer contracts remain the key valuation milestones.
Post Disclaimer
The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.
This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.
The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.
Related Posts
